Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study-Reference-Cited by-同舟云学术

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study

Published:2014-02 Issue:1 Volume:7 Page:55-64
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Rembielak Agata I.,Jain Pooja,Jackson Andrew S.,Green Melanie M.,Santorelli Gillian R.,Whitfield Gillian A.,Crellin Adrian,Garcia-Alonso Angel,Radhakrishna Ganesh,Cullen James,Taylor M. Ben,Swindell Ric,West Catharine M.,Valle Juan,Saleem Azeem,Price Patricia M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. The integration of chemoradiation in the care of patient with localized pancreatic cancer;Crane;Cancer Radiother,2009

2. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy;Sultana;Br J Cancer,2007

3. Guidance on the Use of Gemcitabine for the Treatment of Pancreatic Cancer,2001

4. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer;Iacobuzio-Donahue;J Clin Oncol,2009

5. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer;Ben-Josef;Int J Radiat Oncol Biol Phys,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma;Journal for ImmunoTherapy of Cancer;2023-04

2. Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy;Materials;2021-06-04

3. Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis;Oncology;2019-10-02

4. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches;Radiation Oncology;2019-08-08

5. Biodistribution, pharmacokinetics and radioimmunotherapy of 188Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice;Investigational New Drugs;2019-01-05